Navigation Links
Relationship between prostate information and lower urinary-tract symptoms evident
Date:11/13/2008

Arnhem, 13 November 2008 -- In the December issue of European Urology (http://www.elsevier.com/locate/eururo) Dr. Curtis Nickel and associates report on the evidence of a relationship between prostate inflammation and lower urinary tract symptoms (LUTS) in men enrolled in the REDUCE trial.

The REDUCE (Reduction by DUtasteride of prostate Cancer Events) trial is a 4-year, phase-III placebo-controlled study that evaluates whether the drug dutasteride decreases the risk of biopsy-detectable prostate cancer. Dutasteride is a 5-alpha-reductase inhibitor, a drug that inhibits the conversion of testosterone into dihydrotestosterone (DHT), a hormone that may cause benign prostatic obstruction. The trial involves men with a negative prostate biopsy. The men were given either dutasteride or a placebo and followed for 4 years.

According to Dr Curtis Nickel, the lead researcher in the trial: "The data from the entrance biopsy have enabled additional investigations to be made, including examination of the relationship between prostate inflammation and LUTS."

The study is remarkable for its scope, which includes data on 8,224 men. A majority of participants had chronic inflammation at baseline. Total IPSS (International Prostate Symptom Score; the most widely used gauge of lower urinary tract symptoms associated with an enlarging prostate) and subscores were higher in the group of patients with chronic inflammation at baseline compared to those with no chronic inflammation. The differences were small but statistically significant. A regression analysis was performed. It revealed that higher values of age and average chronic inflammation were significantly associated with higher IPSS scores.

According to Dr Nickel, "The study entry criteria that selected older men and decreased enrollment of men with a greater degree of inflammation and LUTS may have limited the strength of the relationship between the degree of chronic inflammation and LUTS. It may actually be stronger."

The impact of baseline prostate inflammation on the progression of LUTS and/or associated complications will be determined during a 4-year follow-up study.


'/>"/>

Contact: Joan Anuels
j.anuels@elsevier.com
31-204-852-461
Elsevier
Source:Eurekalert

Related medicine news :

1. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. New study examines brain-gut relationship in those suffering with stomach pain or discomfort
4. Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators
5. Alter-G Forging New Relationships
6. MD On-Line Expands Relationship with Aetna for Direct Claim Submission
7. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
8. Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRTs Centralized Cardiac Safety Services
9. Cholesterol-Stroke Relationship Puzzles Researchers
10. Aging improves parent, child relationships, research shows
11. Saint Barnabas Health Care System Expands Business Relationship with Thomson Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... ... July 24, 2017 , ... Three experts will be ... 59th Annual Meeting & Exhibition, to be held in Denver, CO on July ... and journalists can visit the AAPM Facebook page to watch three speakers present ...
(Date:7/23/2017)... ... July 23, 2017 , ... Better education to coaches ... presenting their work today at the American Orthopaedic Society for Sports Medicine’ ... first one to prospectively document the association between sports specialization and lower extremity ...
(Date:7/23/2017)... ... July 23, 2017 , ... ... Florida Pain Relief Group – Melbourne, a practice owned by Physician Partners of ... interventional pain management, Dr. Stern also is certified in pediatrics, emergency medicine and ...
(Date:7/22/2017)... , ... July 22, 2017 , ... ... year with the majority of patients not requiring pain medication after three months ... Sports Medicine’s Annual Meeting today in Toronto, Ontario, Canada found that those ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... financial consultations to communities in the greater Denver region, is announcing a charity ... with a very rare kind of epilepsy. , Until a few months ago, ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/15/2017)... 2017 Enterin Inc., a Philadelphia ... (PD), today announced the completion of a $12.7 million Series ... III, as well as the participation of existing investors. ... have the support of New Ventures III and our current ... of the potential of our platform technology to transform the ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
Breaking Medicine Technology: